FIELD: medicine.
SUBSTANCE: invention refers to biotechnology. Offered application of sgk1 antibody is referred to as such providing change of sgk1 expression and/or function in eukaryotic cells, for diagnostics of diseases associated with inadequate activity of tissue factor. Discovered method concerns diagnostics of specified diseases and diagnostic set for detection of specified diseases based on antibody for diagnostics of diseases associated with inadequate activity of tissue factor. Invention application includes detection of tissue factor expression provided by change of sgk1, what can be applied in medicine for diagnostics of diseases associated with inadequate activity of tissue factor.
EFFECT: potential diagnostics of diseases associated with inadequate activity of tissue factor.
12 cl, 2 dwg
Authors
Dates
2008-08-10—Published
2003-03-03—Filed